𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn's disease on infliximab

✍ Scribed by Claire Pillot; Jean-Baptiste Chevaux; Nadine Petitpain; Laurent Peyrin-Biroulet


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
40 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Salmonella septic arthritis in a patient
✍ Jean Y. Rim; Allan R. Tenorio πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 2 views

The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of

Severe Legionella pneumophila pneumonia
✍ Florian Beigel; Matthias JΓΌrgens; Levent Filik; Lutz Bader; Christian LΓΌck; Burk πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea

Splenic tuberculosis in a patient with C
✍ Maria Cappello; Claudia Randazzo; Giulia Rizzuto; Celestino Bonura; Gaetano Di V πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 1 views

FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).

Treatment-associated acute myeloid leuke
✍ Koushik K. Das; Ha Thanh Nishino; Andrew T. Chan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

To the Editor: Immunomodulatory therapies such as 6-mercaptopurine (6-MP) and azathioprine provide high remission rates and success in avoiding steroid dependence in patients with inflammatory bowel disease (IBD). However, these treatments are not without adverse effects including leukopenia, liver